These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23418396)

  • 101. The Wnt pathway protein Dvl1 targets somatostatin receptor 2 for lysosome-dependent degradation.
    Carr HS; Zuo Y; Frost JA
    J Biol Chem; 2023 May; 299(5):104645. PubMed ID: 36965619
    [TBL] [Abstract][Full Text] [Related]  

  • 102. SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors.
    Castellnou S; Vasiljevic A; Lapras V; Raverot V; Alix E; Borson-Chazot F; Jouanneau E; Raverot G; Lasolle H
    Endocr Connect; 2020 Feb; 9(3):243-53. PubMed ID: 32101529
    [TBL] [Abstract][Full Text] [Related]  

  • 103. WITHDRAWN: Highly efficient agonist-induced internalization of somatostatin SST2 receptor in mouse dorsal root ganglion and spinal cord: Molecular evidence for mechanism of somatostatin inhibits neuropathic pain.
    Xiang Q; Wang CL; Song S; Shi TJ
    Regul Pept; 2013 Mar; ():. PubMed ID: 23507148
    [No Abstract]   [Full Text] [Related]  

  • 104. Expression of Concern: Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells.
    Peverelli E; Busnelli M; Vitali E; Giardino E; Galés C; Lania AG; Beck-Peccoz P; Chini B; Mantovani G; Spada A
    J Cell Sci; 2022 Nov; 135(22):. PubMed ID: 36441052
    [No Abstract]   [Full Text] [Related]  

  • 105. Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas.
    Modena D; Moras ML; Sandrone G; Stevenazzi A; Vergani B; Dasgupta P; Kliever A; Gulde S; Marangelo A; Schillmaier M; Luque RM; Bäuerle S; Pellegata NS; Schulz S; Steinkühler C
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444563
    [TBL] [Abstract][Full Text] [Related]  

  • 106. In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies.
    Fritzwanker S; Nagel F; Kliewer A; Stammer V; Schulz S
    Commun Biol; 2023 Apr; 6(1):419. PubMed ID: 37061609
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening.
    Kaufmann J; Blum NK; Nagel F; Schuler A; Drube J; Degenhart C; Engel J; Eickhoff JE; Dasgupta P; Fritzwanker S; Guastadisegni M; Schulte C; Miess-Tanneberg E; Maric HM; Spetea M; Kliewer A; Baumann M; Klebl B; Reinscheid RK; Hoffmann C; Schulz S
    Commun Biol; 2022 Nov; 5(1):1206. PubMed ID: 36352263
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy.
    Kotzerke J; Buesser D; Naumann A; Runge R; Huebinger L; Kliewer A; Freudenberg R; Brogsitter C
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626117
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Pasireotide in the Personalized Treatment of Acromegaly.
    Puig-Domingo M; Bernabéu I; Picó A; Biagetti B; Gil J; Alvarez-Escolá C; Jordà M; Marques-Pamies M; Soldevila B; Gálvez MA; Cámara R; Aller J; Lamas C; Marazuela M
    Front Endocrinol (Lausanne); 2021; 12():648411. PubMed ID: 33796079
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Functional Amyloids and their Possible Influence on Alzheimer Disease.
    Lau A; Bourkas M; Lu YQQ; Ostrowski LA; Weber-Adrian D; Figueiredo C; Arshad H; Shoaei SZS; Morrone CD; Matan-Lithwick S; Abraham KJ; Wang H; Schmitt-Ulms G
    Discoveries (Craiova); 2017 Oct; 5(4):e79. PubMed ID: 32309597
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists.
    Mann A; Moulédous L; Froment C; O'Neill PR; Dasgupta P; Günther T; Brunori G; Kieffer BL; Toll L; Bruchas MR; Zaveri NT; Schulz S
    Sci Signal; 2019 Mar; 12(574):. PubMed ID: 30914485
    [TBL] [Abstract][Full Text] [Related]  

  • 112. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.
    Günther T; Tulipano G; Dournaud P; Bousquet C; Csaba Z; Kreienkamp HJ; Lupp A; Korbonits M; Castaño JP; Wester HJ; Culler M; Melmed S; Schulz S
    Pharmacol Rev; 2018 Oct; 70(4):763-835. PubMed ID: 30232095
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in rats.
    Tarasco E; Seebeck P; Pfundstein S; Daly AF; Eugster PJ; Harris AG; Grouzmann E; Lutz TA; Boyle CN
    Endocrine; 2017 Oct; 58(1):124-133. PubMed ID: 28822091
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Somatostatin regulates NHE8 protein expression via the ERK1/2 MAPK pathway in DSS-induced colitis mice.
    Li X; Cai L; Xu H; Geng C; Lu J; Tao L; Sun D; Ghishan FK; Wang C
    Am J Physiol Gastrointest Liver Physiol; 2016 Nov; 311(5):G954-G963. PubMed ID: 27686614
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Paradoxical and atypical responses to pasireotide in aggressive ACTH-secreting pituitary tumors.
    Greenman Y; Stern N
    Pituitary; 2016 Dec; 19(6):605-611. PubMed ID: 27639583
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking.
    Lehmann A; Kliewer A; Günther T; Nagel F; Schulz S
    Mol Endocrinol; 2016 Jun; 30(6):645-59. PubMed ID: 27101376
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Molecular Mechanisms Linking Autonomic Dysfunction and Impaired Cardiac Contractility in Critical Illness.
    Ackland GL; Whittle J; Toner A; Machhada A; Del Arroyo AG; Sciuso A; Jenkins N; Dyson A; Struthers R; Sneyd JR; Minto G; Singer M; Shah AM; Gourine AV
    Crit Care Med; 2016 Aug; 44(8):e614-24. PubMed ID: 26950003
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Protein phosphatase modulation of somatostatin receptor signaling in the mouse hippocampus.
    Lucas SJ; Armstrong DL
    Neuropharmacology; 2015 Dec; 99():232-41. PubMed ID: 26196943
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms.
    Lehmann A; Kliewer A; Märtens JC; Nagel F; Schulz S
    PLoS One; 2014; 9(3):e91526. PubMed ID: 24637622
    [TBL] [Abstract][Full Text] [Related]  

  • 120. PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.
    Briest F; Grabowski P
    Theranostics; 2014; 4(4):336-65. PubMed ID: 24578720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.